Galapagos NV
GLPG
#5075
Rank
A$2.66 B
Marketcap
A$39.65
Share price
0.00%
Change (1 day)
-20.11%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of March 2026 : A$5.58 Billion

According to Galapagos NV's latest financial reports the company's total assets are A$5.58 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2026)

Total assets by year

Year Total assets Change
2024-12-31A$6.91 B-2.14%
2023-12-31A$7.07 B-5.26%
2022-12-31A$7.46 B-8.01%
2021-12-31A$8.11 B-11.3%
2020-12-31A$9.14 B-5.81%
2019-12-31A$9.70 B315.38%
2018-12-31A$2.33 B18.25%
2017-12-31A$1.97 B25.05%
2016-12-31A$1.58 B138.02%
2015-12-31A$0.66 B65.24%
2014-12-31A$0.40 B-9.66%
2013-12-31A$0.44 B48.53%
2012-12-31A$0.29 B46.85%
2011-12-31A$0.20 B-19.69%
2010-12-31A$0.25 B10.81%
2009-12-31A$0.22 B-2.66%
2008-12-31A$0.23 B-5.2%
2007-12-31A$0.24 B-11.49%
2006-12-31A$0.28 B112.51%
2005-12-31A$0.13 B382.48%
2004-12-31A$27.36 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$287.27 B 5,046.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$157.91 B 2,729.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$195.14 B 3,396.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$211.89 B 3,696.20%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$184.01 B 3,196.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$163.04 B 2,820.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$119.06 B 2,033.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$0.51 B-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$57.25 B 925.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel